1. Home
  2. CBL vs AVDL Comparison

CBL vs AVDL Comparison

Compare CBL & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • AVDL
  • Stock Information
  • Founded
  • CBL 1978
  • AVDL 2015
  • Country
  • CBL United States
  • AVDL Ireland
  • Employees
  • CBL N/A
  • AVDL N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBL Real Estate
  • AVDL Health Care
  • Exchange
  • CBL Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • CBL 828.5M
  • AVDL 784.6M
  • IPO Year
  • CBL 1993
  • AVDL 1996
  • Fundamental
  • Price
  • CBL $24.40
  • AVDL $9.39
  • Analyst Decision
  • CBL
  • AVDL Strong Buy
  • Analyst Count
  • CBL 0
  • AVDL 7
  • Target Price
  • CBL N/A
  • AVDL $18.86
  • AVG Volume (30 Days)
  • CBL 102.5K
  • AVDL 1.3M
  • Earning Date
  • CBL 05-05-2025
  • AVDL 05-07-2025
  • Dividend Yield
  • CBL 11.48%
  • AVDL N/A
  • EPS Growth
  • CBL 2069.88
  • AVDL N/A
  • EPS
  • CBL 2.16
  • AVDL N/A
  • Revenue
  • CBL $528,212,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • CBL N/A
  • AVDL $50.53
  • Revenue Next Year
  • CBL N/A
  • AVDL $32.33
  • P/E Ratio
  • CBL $11.28
  • AVDL N/A
  • Revenue Growth
  • CBL 0.03
  • AVDL 252.64
  • 52 Week Low
  • CBL $21.10
  • AVDL $6.38
  • 52 Week High
  • CBL $33.54
  • AVDL $17.85
  • Technical
  • Relative Strength Index (RSI)
  • CBL 49.50
  • AVDL 64.66
  • Support Level
  • CBL $23.92
  • AVDL $8.55
  • Resistance Level
  • CBL $24.92
  • AVDL $9.98
  • Average True Range (ATR)
  • CBL 0.61
  • AVDL 0.51
  • MACD
  • CBL 0.27
  • AVDL 0.10
  • Stochastic Oscillator
  • CBL 72.51
  • AVDL 72.04

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: